CIK 0001664710
- Non-accelerated filer
- Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811173868
- Phone
- +1 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,619
- in 1 filing, $6K under 10b5-1 plans
Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-11 | Knowles Julius Director | Sale | −270 | $62.79 | $17K | 458,172 |
| 2021-02-11 | Knowles Julius Director | Sale | −2,335 | $63.83 | $149K | 684,916 |
| 2021-02-11 | Knowles Julius Director | Sale | −1,526 | $63.83 | $97K | 456,646 |
| 2021-02-11 | Knowles Julius Director | Sale | −1,461 | $64.87 | $95K | 683,455 |
| 2021-02-11 | Knowles Julius Director | Sale | −952 | $64.87 | $62K | 455,694 |
| 2021-02-11 | Knowles Julius Director | Sale | −2,418 | $65.80 | $159K | 681,037 |
| 2021-02-11 | Knowles Julius Director | Sale | −1,575 | $65.80 | $104K | 454,119 |
| 2021-02-11 | Knowles Julius Director | Sale | −316 | $66.65 | $21K | 680,721 |
| 2021-02-11 | Knowles Julius Director | Sale | −206 | $66.65 | $14K | 453,913 |
| 2021-02-11 | Knowles Julius Director | Sale | −53 | $67.99 | $4K | 680,668 |
| 2021-02-11 | Knowles Julius Director | Sale | −35 | $67.98 | $2K | 453,878 |
| 2021-02-11 | Ordonez Claudia Chief Medical Officer | Exercise or conversion | +1,000 | $0.48 | $480 | 1,000 |
| 2021-02-11 | Ordonez Claudia Chief Medical Officer | Sale | −175 | $63.10 | $11K | 825 |
| 2021-02-11 | Ordonez Claudia Chief Medical Officer | Sale | −312 | $64.17 | $20K | 513 |
| 2021-02-11 | Ordonez Claudia Chief Medical Officer | Sale | −216 | $65.35 | $14K | 297 |
| 2021-02-11 | Ordonez Claudia Chief Medical Officer | Sale | −295 | $66.19 | $20K | 2 |
| 2021-02-11 | Ordonez Claudia Chief Medical Officer | Sale | −2 | $68.05 | $136 | 0 |
| 2021-02-11 | Ordonez Claudia Chief Medical Officer | Exercise or conversion · Employee Stock Option (right to buy) | −1,000 | 102,211 | ||
| 2021-02-11 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +5,300 | $0.30 | $2K | 33,291 |
| 2021-02-11 | Lachey Jennifer Chief Scientific Officer | Sale | −447 | $62.85 | $28K | 32,844 |
Page 28 of 36 · 707 trades